Docosahexaenoic acid mediates peroxisomal elongation, a prerequisite for peroxisome division

Journal of Cell Science

Volumn 125, Issue 3, 2012, Pages 589-602

  Itoyama, Akinori ^a   Honsho, Masanori ^a   Abe, Yuichi ^a   Moser, Ann ^b   Yoshida, Yumi ^a   Fujiki, Yukio ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Division; Dynamin like protein 1; Elongation; Fatty acid oxidation; Fis1; Fission; Peroxin pex11p; Peroxisome morphogenesis

Indexed keywords

ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; CELL PROTEIN; DOCOSAHEXAENOIC ACID; DYNAMIN LIKE PROTEIN 1; DYNASORE; FATTY ACID; PEX11P BETA PROTEIN; PEX16P PROTEIN; PROTEIN INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL DIVISION; CELL ELONGATION; CELL PROLIFERATION; CELL STIMULATION; DISORDERS OF PEROXISOMAL FUNCTIONS; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MORPHOGENESIS; OLIGOMERIZATION; PEROXISOME; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN FIBROBLAST; TIME LAPSE IMAGING;

3-HYDROXYACYL COA DEHYDROGENASES; ACYL-COA OXIDASE; BASE SEQUENCE; CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; ENOYL-COA HYDRATASE; FATTY ACIDS; FIBROBLASTS; GTP PHOSPHOHYDROLASES; HUMANS; ISOMERASES; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; OXIDATION-REDUCTION; PEROXISOMAL DISORDERS; PEROXISOMES; PROTEIN MULTIMERIZATION; RNA, SMALL INTERFERING; TIME-LAPSE IMAGING;

EID: 84858142449     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.087452     Document Type: Article

References (67)

1. Abe, I. and Fujiki, Y. (1998). cDNA cloning and characterization of a constitutively expressed isoform of the human peroxin Pex11p. Biochem. Biophys. Res. Commun. 252, 529-533.
2. Abe, I., Okumoto, K., Tamura, S. and Fujiki, Y. (1998). Clofibrate-inducible, 28-kDa peroxisomal integral membrane protein is encoded by PEX11. FEBS Lett. 431, 468-472.
3. Barnett, P., Tabak, H. F. and Hettema, E. H. (2000). Nuclear receptors arose from pre-existing protein modules during evolution. Trends Biochem. Sci. 25, 227-228.
4. Bligh, E. G. and Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Can. J. Med. Sci. 37, 911-917.
5. Chang, C. C., South, S., Warren, D., Jones, J., Moser, A. B., Moser, H. W. and Gould, S. J. (1999). Metabolic control of peroxisome abundance. J. Cell Sci. 112, 1579-1590.
6. Crane, D. I. and Masters, C. J. (1986). The effect of clofibrate on the phospholipid composition of the peroxisomal membranes in mouse liver. Biochim. Biophys. Acta. 876, 256-263.
7. Delille, H. K., Agricola, B., Guimaraes, S. C., Borta, H., Lüers, G. H., Fransen, M. and Schrader, M. (2010). Pex11pβ-mediated growth and division of mammalian peroxisomes follows a maturation pathway. J. Cell Sci. 123, 2750-2762.
8. Ferdinandusse, S., Denis, S., Mooijer, P. A., Zhang, Z., Reddy, J. K., Spector, A. A. and Wanders, R. J. (2001). Identification of the peroxisomal β-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J. Lipid Res. 42, 1987-1995.
9. Ferdinandusse, S., Denis, S., Mooijer, P. A., Dekker, C., Duran, M., Soorani-Lunsing, R. J., Boltshauser, E., Macaya, A., Gärtner, J., Majoie, C. B. et al. (2006). Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ann. Neurol. 59, 92-104.
10. Ferdinandusse, S., Denis, S., Hogenhout, E. M., Koster, J., van Roermund, C. W. T., Ijlst, L., Moser, A. B., Wanders, R. J. A. and Waterham, H. R. (2007). Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum. Mutat. 28, 904-912.
11. Fujiki, Y. (2000). Peroxisome biogenesis and peroxisome biogenesis disorders. FEBS Lett. 476, 42-46.
12. Funato, M., Shimozawa, N., Nagase, T., Takemoto, Y., Suzuki, Y., Imamura, Y., Matsumoto, T., Tsukamoto, T., Kojidani, T., Osumi, T. et al. (2006). Aberrant peroxisome morphology in peroxisomal β-oxidation enzyme deficiencies. Brain Dev. 5, 287-292.
13. Gandre-Babbe, S. and van der Bliek, A. M. (2008). The novel tail-anchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. Mol. Biol. Cell 19, 2402-2412.
14. Gondcaille, C., Depreter, M., Fourcade, S., Lecca, M. R., Leclercq, S., Martin, P. G., Pineau, T., Cadepond, F., ElEtr, M., Bertrand, N. et al. (2005). Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J. Cell Biol. 169, 93-104.
15. Gould, S. J. and Valle, D. (2000). Peroxisome biogenesis disorders: genetics and cell biology. Trends in Genetics 16, 340-345.
16. Guo, T., Gregg, C., Boukh-Viner, T., Kyryakov, P., Goldberg, A., Bourque, S., Banu, F., Haile, S., Milijevic, S., San, K. H. et al. (2007). A signal from inside the peroxisome initiates its division by promoting the remodeling of the peroxisomal membrane. J. Cell Biol. 177, 289-303.
17. Honsho, M., Tamura, S., Shimozawa, N., Suzuki, Y., Kondo, N. and Fujiki, Y. (1998). Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am. J. Hum. Genet. 63, 1622-1630.
18. Ingerman, E., Perkins, E. M., Marino, M., Mears, J. A., McCaffery, J. M., Hinshaw, J. E. and Nunnari, J. (2005). Dnm1 forms spirals that are structurally tailored to fit mitochondria. J. Cell Biol. 170, 1021-1027.
19. Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A. and Smith, K. D. (1998). Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat. Med. 4, 1261-1268.
20. Kemp, S., Pujol, A., Waterham, H. R., van Geel, B. M., Boehm, C. D., Raymond, G. V., Cutting, G. R., Wanders, R. J. and Moser, H. W. (2001). ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum. Mutat. 18, 499-515.
21. Kim, P. K., Mullen, R. T., Schumann, U. and Lippincott-Schwartz, J. (2006). The origin and maintenance of mammalian peroxisomes involves a de novo PEX16-dependent pathway from the ER. J. Cell Biol. 173, 521-532.
22. Kobayashi, S., Tanaka, A. and Fujiki, Y. (2007). Fis1, DLP1, and Pex11p coordinately regulate peroxisome morphogenesis. Exp. Cell Res. 313, 1675-1686.
23. Koch, A., Thiemann, M., Grabenbauer, M., Yoon, Y., McNiven, M. A. and Schrader, M. (2003). Dynamin-like protein 1 is involved in peroxisomal fission. J. Biol. Chem. 278, 8597-8605.
24. Koch, A., Schneider, G., Lüers, G. H. and Schrader, M. (2004). Peroxisome elongation and constriction but not fission can occur independently of dynamin-like protein 1. J. Cell Sci. 117, 3995-4006.
25. Koch, A., Yoon, Y., Bonekamp, N. A., McNiven, M. A. and Schrader, M. (2005). A role for Fis1 in both mitochondrial and peroxisomal fission in mammalian cells. Mol. Biol. Cell 16, 5077-5086.
26. Koch, J., Pranjic, K., Huber, A., Ellinger, A., Hartig, A., Kragler, F. and Brocard, C. (2010). PEX11 family members are membrane elongation factors that coordinate peroxisome proliferation and maintenance. J. Cell Sci. 123, 3389-3400.
27. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G. and Wahli, W. (1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791.
28. Lazarow, P. B. and Fujiki, Y. (1985). Biogenesis of peroxisomes. Ann. Rev. Cell Biol. 1, 489-530.
29. Li, X. and Gould, S. J. (2002). PEX11 promotes peroxisome division independently of peroxisome metabolism. J. Cell Biol. 156, 643-651.
30. Li, X. and Gould, S. J. (2003). The dynamin-like GTPase DLP1 is essential for peroxisome division and is recruited to peroxisomes in part by PEX11. J. Biol. Chem. 278, 17012-17020.
31. Li, X., Baumgart, E., Dong, G. X., Morrell, J. C., Jimenez-Sanchez, G., Valle, D., Smith, K. D. and Gould, S. J. (2002a). PEX11 is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation. Mol. Cell. Biol. 22, 8226-8240.
32. Li, X., Baumgart, E., Morrell, J. C., Jimenez-Sanchez, G., Valle, D. and Gould, S. J. (2002b). PEX11β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol. Cell. Biol. 22, 4358-4365.
33. Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C. and Kirchhausen, T. (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839-850.
34. Marshall, P. A., Dyer, J. M., Quick, M. E. and Goodman, J. M. (1996). Redoxsensitive homodimerization of Pex11p: a proposed mechanism to regulate peroxisomal division. J. Cell Biol. 135, 123-137.
35. Martinez, M. (1995). Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications. J. Inherit. Metab. Dis. 18 Suppl. 1, 61-75.
36. Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P. R. F., Moser, H., Poustka, A.-M., Mandel, J.-L. and Aubourg, P. (1993). Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726-730.
37. Mukai, S. and Fujiki, Y. (2006). Molecular mechanisms of import of peroxisometargeting signal type 2 (PTS2) proteins by PTS2 receptor Pex7p and PTS1 receptor Pex5pL. J. Biol. Chem. 281, 37311-37320.
38. Mukai, S., Ghaedi, K. and Fujiki, Y. (2002). Intracellular localization, function, and dysfunction of the peroxisome-targeting signal type 2 receptor, Pex7p, in mammalian cells. J. Biol. Chem. 277, 9548-9561.
39. Okumoto, K., Itoh, R., Shimozawa, N., Suzuki, Y., Tamura, S., Kondo, N. and Fujiki, Y. (1998a). Mutation in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum. Mol. Genet. 7, 1399-1405.
40. Okumoto, K., Shimozawa, N., Kawai, A., Tamura, S., Tsukamoto, T., Osumi, T., Moser, H., Wanders, R. J. A., Suzuki, Y., Kondo, N. et al. (1998b). PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of Pex12p. Mol. Cell. Biol. 18, 4324-4336.
41. Pitts, K. R., Yoon, Y., Krueger, E. W. and McNiven, M. A. (1999). The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells. Mol. Biol. Cell 10, 4403-4417.
42. Poll-The, B. T., Roels, E., Ogier, H., Scotto, J., Vamecq, J., Schutgens, R. B. H., van Roermund, C. W. T., van Wijland, M. J. A., Schram, A. W., Tager, J. M. et al. (1988). A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am. J. Hum. Genet. 42, 422-434.
43. Santos, M. J., Imanaka, T., Shio, H., Small, G. M. and Lazarow, P. B. (1988). Peroxisomal membrane ghosts in Zellweger syndrome- aberrant organelle assembly. Science 239, 1536-1538.
44. Schollenberger, L., Gronemeyer, T., Huber, C. M., Lay, D., Wiese, S., Meyer, H. E., Warscheid, B., Saffrich, R., Peränen, J., Gorgas, K. et al. (2010). RhoA regulates peroxisome association to microtubules and the actin cytoskeleton. PLoS ONE 5, e13886.
45. Schrader, M., Reuber, B. E., Morrell, J. C., Jimenez-Sanchez, G., Obie, C., Stroh, T. A., Valle, D., Schroer, T. A. and Gould, S. J. (1998). Expression of PEX11β mediates peroxisome proliferation in the absence of extracellular stimuli. J. Biol. Chem. 273, 29607-29614.
46. Shimizu, N., Itoh, R., Hirono, Y., Otera, H., Ghaedi, K., Tateishi, K., Tamura, S., Okumoto, K., Harano, T., Mukai, S. et al. (1999). The peroxin Pex14p: cDNA cloning by functional complementation on a Chinese hamster ovary cell mutant, characterization, and functional analysis. J. Biol. Chem. 274, 12593-12604.
47. Shimizu, M., Takeshita, A., Tsukamoto, T., Gonzalez, F. J. and Osumi, T. (2004). Tissue-selective, bidirectional regulation of PEX11α and perilipin genes through a common peroxisome proliferator response element. Mol. Cell. Biol. 24, 1313-1323.
48. Shimizu, T., Ohto, T. and Kita, Y. (2006). Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life 58, 328-333.
49. Shimozawa, N., Tsukamoto, T., Suzuki, Y., Orii, T. and Fujiki, Y. (1992a). Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. J. Clin. Invest. 90, 1864-1870.
50. Shimozawa, N., Tsukamoto, T., Suzuki, Y., Orii, T., Shirayoshi, Y., Mori, T. and Fujiki, Y. (1992b). A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science 255, 1132-1134.
51. Shindou, H. and Shimizu, T. (2009). Acyl-CoA:lysophospholipid acyltransferases. J. Biol. Chem. 284, 1-5.
52. Smith, K. D., Kemp, S., Braiterman, L. T., Lu, J. F., Wei, H. M., Geraghty, M., Stetten, G., Bergin, J. S., Pevsner, J. and Watkins, P. A. (1999). X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem. Res. 24, 521-535.
53. Su, H. M., Moser, A. B., Moser, H. W. and Watkins, P. A. (2001). Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis. J. Biol. Chem. 276, 38115-38120.
54. Subramani, S. (1998). Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. Physiol. Rev. 78, 171-188.
55. Suzuki, Y., Shimozawa, N., Yajima, S., Yamaguchi, S., Orii, T. and Hashimoto, T. (1991). Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases. Biochem. Pharmacol. 41, 453-456.
56. Suzuki, Y., Jiang, L. L., Souri, M., Miyazawa, S., Fukuda, S., Zhang, Z., Une, M., Shimozawa, N., Kondo, N., Orii, T. and Hashimoto, T. (1997). D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder. Am. J. Hum. Genet. 61, 1153-1162.
57. Tanaka, A., Okumoto, K. and Fujiki, Y. (2003). cDNA cloning and characterization of the third isoform of human peroxin Pex11p. Biochem. Biophys. Res. Commun. 300, 819-823.
58. Tanaka, A., Kobayashi, S. and Fujiki, Y. (2006). Peroxisome division is impaired in a CHO cell mutant with an inactivating point-mutation in dynamin-like protein 1 gene. Exp. Cell Res. 312, 1671-1684.
59. Tsukamoto, T., Yokota, S. and Fujiki, Y. (1990). Isolation and characterization of Chinese hamster ovary cell mutants defective in assembly of peroxisomes. J. Cell Biol. 110, 651-660.
60. Wanders, R. J. (2004). Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol. Genet. Metab. 83, 16-27.
61. Wanders, R. J. and Waterham, H. R. (2006). Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochim. Biophys. Acta 1763, 1707-1720.
62. Warren, D. S., Morrell, J. C., Moser, H. W., Valle, D. and Gould, S. J. (1998). Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. Am. J. Hum. Genet. 63, 347-359.
63. Waterham, H. R., Koster, J., van Roermund, C. W. T., Mooyer, P. A. W., Wanders, R. J. A. and Leonard, J. V. (2007). A lethal defect of mitochondrial and peroxisomal fission. N. Engl. J. Med. 356, 1736-1741.
64. Wei, H., Kemp, S., McGuinness, M. C., Moser, A. B. and Smith, K. D. (2000). Pharmacological induction of peroxisomes in peroxisome biogenesis disorders. Ann. Neurol. 47, 286-296.
65. Wiemer, E. A. C., Wenzel, T., Deerinck, T. J., Ellisman, M. H. and Subramani, S. (1997). Visualization of the peroxisomal compartment in living mammalian cells: dynamic behavior and association with microtubules. J. Cell Biol. 136, 71-80.
66. Yang, J., Han, X. and Gross, R. W. (2003). Identification of hepatic peroxisomal phospholipase A(2) and characterization of arachidonic acid-containing choline glycerophospholipids in hepatic peroxisomes. FEBS Lett. 546, 247-250.
67. Yoon, Y. S., Yoon, D. S., Lim, I. K., Yoon, S. H., Chung, H. Y., Rojo, M., Malka, F., Jou, M. J., Martinou, J. C. and Yoon, G. (2006). Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J. Cell Physiol. 209, 468-480.